Australia’s Creso Pharma cleared to sell CBD pet product line in Uruguay

CBD 20% Discount

Authorities in Uruguay have given Australia-based pharmaceutical company Creso Pharma the green light to market its line of CBD animal products in the South American country.

Creso Pharma, which offers a range of cannabis-derived wellness and lifestyle products for humans and animals, said Monday it received regulatory approval from Uruguay’s Ministry of Agriculture and Animal Feed to sell its patented “anibidiol” pet product line in the country.

The approval, secured through its partner Adler Laboratories Uruguay, coincides with a purchase order for some 175,000 packages of the product, to be delivered in the first quarter of next year.

The company said its product line was the first hemp-based CBD complementary feed approved for pets in Latin America and heralded the news as a “key strategic milestone” in its ambitions to expand across global markets.

“The company’s entry into the Latin American market more broadly represents a major strategic development and significant growth opportunity,” Jorge Wernli, Creso commercial director, said in a statement.

Creso Pharma Ltd. trades on the Australian stock exchange as CPH.

Originally Published on 2020 12 22 by Monica Raymunt | Hemp Industry Daily

Thank you for joining us today for our latest news post. If you have any questions or comments about this post, we’d love to hear from you in the comments! Join the newsletter to stay up to date on the latest Industry News and keep an eye out for our next news article!

Disclaimer: This content was sourced from Hemp Industry Daily and republished to our website to add value and additional content for our readers. In order to maintain the safety, functionality, and integrity of, the sourced content may have been altered. To access the original content, please click the link below:

Pin It on Pinterest

Share This